Reported 5 days ago
Eli Lilly has announced an investment of $4.5 billion to enhance its manufacturing and drug development capabilities, including a new advanced manufacturing center near its Indianapolis headquarters. This initiative follows significant revenue growth from its diabetes and weight-loss treatments, prompting the company to expand its production facilities, including a $9 billion investment in Lebanon, Indiana.
Source: YAHOO